- Home
- GNLX vs ECF Comparison
GNLX vs ECF Comparison
Compare GNLX & ECF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- ECF
- Stock Information
- Founded
- GNLX 2001
- ECF 1986
- Country
- GNLX United States
- ECF United States
- Employees
- GNLX N/A
- ECF N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- ECF Finance/Investors Services
- Sector
- GNLX Health Care
- ECF Finance
- Exchange
- GNLX Nasdaq
- ECF Nasdaq
- Market Cap
- GNLX 128.0M
- ECF 150.0M
- IPO Year
- GNLX 2023
- ECF N/A
- Fundamental
- Price
- GNLX $3.78
- ECF $10.97
- Analyst Decision
- GNLX Strong Buy
- ECF
- Analyst Count
- GNLX 5
- ECF 0
- Target Price
- GNLX $16.20
- ECF N/A
- AVG Volume (30 Days)
- GNLX 89.3K
- ECF 57.7K
- Earning Date
- GNLX 08-07-2025
- ECF 01-01-0001
- Dividend Yield
- GNLX N/A
- ECF 6.42%
- EPS Growth
- GNLX N/A
- ECF N/A
- EPS
- GNLX N/A
- ECF 0.46
- Revenue
- GNLX N/A
- ECF N/A
- Revenue This Year
- GNLX N/A
- ECF N/A
- Revenue Next Year
- GNLX N/A
- ECF N/A
- P/E Ratio
- GNLX N/A
- ECF $17.61
- Revenue Growth
- GNLX N/A
- ECF N/A
- 52 Week Low
- GNLX $1.95
- ECF $7.02
- 52 Week High
- GNLX $5.89
- ECF $8.91
- Technical
- Relative Strength Index (RSI)
- GNLX 62.02
- ECF 69.08
- Support Level
- GNLX $3.26
- ECF $10.60
- Resistance Level
- GNLX $3.50
- ECF $10.87
- Average True Range (ATR)
- GNLX 0.24
- ECF 0.13
- MACD
- GNLX 0.01
- ECF 0.01
- Stochastic Oscillator
- GNLX 99.47
- ECF 100.00
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About ECF Ellsworth Growth and Income Fund Ltd.
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.